LAP3 and acute respiratory distress syndrome: In vivo, the peptidase activity of ACE2 has been shown to suppress the renin-angiotensin system (RAS system) to improve cardiovascular or kidney diseases as well as acute respiratory distress syndrome (ARDS) (2–4).